You are here:

argatroban, 100mg/ml, concentrate for solution for infusion (Exembol®)

Advice

following a resubmission:

argatroban (Exembol®) is accepted for use within NHS Scotland.

Indication under review: anticoagulation in adult patients with heparin-induced thrombocytopenia type II who require parenteral antithrombotic therapy.

Argatroban produces anticoagulant effects in adults with heparin-induced thrombocytopenia type II.  However there is limited evidence that the anticoagulant effects are associated with a reduction in thrombosis and deaths due to thrombosis.
 

Drug Details

Drug Name: argatroban, 100mg/ml, concentrate for solution for infusion (Exembol®)
SMC Drug ID: 812/12
Manufacturer: Mitsubishi Pharma Europe Ltd
Indication: For anticoagulation in adult patients with heparin-induced thrombocytopenia type II who require parenteral antithrombotic therapy.
BNF Category:
Sub Category: 2.8 Anticoagulants and protamine
Submission Type: Resubmission
Status: Accepted
Date Advice Published: 12 August 2013

Archived Advice

Full submission 12 November 2012

Back